HOME >> BIOLOGY >> NEWS
'Imported' pollution tied to poor air quality in Texas in 2004

Scientists using NASA satellites and other data including computer models and ground sensors have demonstrated that pollutants traveling even thousands of miles can impact air quality.

The study concludes that ozone pollution levels increased significantly in the air above Houston on July 19 and 20, 2004. Researchers attribute this increase in part as a result of smoke transported into the area over the course of a week from forest fires raging in Alaska and Canada. The study is one of only a few that has quantitatively examined the impact of remotely generated pollutants on air quality in the lower atmosphere.

As part of a NASA-led field research project in the summer of 2004, researchers sampled a variety of trace gases and aerosols -- tiny particles suspended in the air -- across North America. During the time of the study, forest fires in western Canada and eastern Alaska were consuming more acres than at any time during the last 50 years. Meteorological conditions carried smoke from these intense fires eastward and southward to the U.S. Gulf Coast.

"The combination of our balloon-borne ozone data and observations by NASA satellites, aircraft, and a network of ground stations provided unprecedented insight into the origins of locally poor air quality in Houston on those two days," said study lead author Gary Morris of Valparaiso University, Valparaiso, Ind.

The researchers relied on imagery from NASA's Moderate Resolution Imaging Spectroradiometer on the Terra satellite, aerosol data from the Total Ozone Mapping Spectrometer satellite, and carbon monoxide data from the Atmospheric Infrared Sounder on the Aqua spacecraft to track the an air mass from the region of forest fires in western Canada and eastern Alaska on July 12-13, 2004. The air mass traveled across Canada, through the mid-western United States, and all the way to Houston, arriving there on July 19.

"We found that with the arrival of the pollutants a
'"/>

Contact: Rob Gutro
robert.J.gutro@nasa.gov
301-286-4044
NASA/Goddard Space Flight Center
21-Sep-2006


Page: 1 2

Related biology news :

1. Air pollution link to clogged arteries
2. UCLA study links air pollution to clogged arteries
3. Scientists track impact of Asian dust and pollution on clouds, climate change
4. Rats on a road trip reveal pollution-heart disease risk
5. Aerosol pollution slows down winds and reduces rainfall
6. Scientists map air pollution using corn grown in US fields
7. Study suggests morning pollution pall for Manchester commuters
8. Rising ocean temperatures, pollution have oysters in hot water
9. UCI scientists use near real-time sensor data to detect coastal ocean pollution
10. Study to forecast side effects of pollution policy
11. Otter research gives insight into lead pollution

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Imported pollution tied poor air quality Texas

(Date:5/21/2013)... , May 21, 2013 Royal Philips Electronics ... the world,s first portable ultrasound with Philips, industry leading ... capability. The CX50 xMATRIX with available Live 3D TEE ... at the EuroPCR, official meeting for the ... Since its launch in 2012, Philips CX50 ...
(Date:5/21/2013)... modifications, which alter the way genes function without ... detected in the blood of pregnant women during ... foretell depression in the weeks after giving birth, ... debilitating. , The findings of the small study ... the journal Molecular Psychiatry . , "Postpartum ...
(Date:5/20/2013)... to the antibiotic colistin are also commonly resistant ... according to a study in mBio , ... for Microbiology. Cross-resistance to colistin and host antimicrobials ... against bacterial attack, could mean that patients with ... a crippled immune response. Colistin is a last-line ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
(Date:5/21/2013)... Toronto, Canada (PRWEB) May 21, 2013 ... there is a strong push within the industry ... Development and Manufacturing Organizations and pharma companies often ... time frames. , Microtablets, developed in collaboration with ... how effective outsourcing can bring products to market ...
(Date:5/21/2013)... May 21, 2013 Many have long ... contributor to acne. Recently physicians from Clinical Psychiatry.com ... stress on the skin, and suggested using hypnotherapy ... the chemicals produced from stress that cause acne. , ... negative feelings acne brings about, stress causes changes in ...
(Date:5/21/2013)... Emerson Resources Inc. , a premier pharmaceutical ... Company’s Chief Executive Officer and Chairman of the Board, ... service. As part of Emerson Resources’ planned leadership succession ... as Dr. Signorino’s successor. , Dr. Signorino is ... a significant contribution to the field during his extensive ...
(Date:5/21/2013)... 21, 2013  MacroGenics, Inc. today announced that ... (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), in ... oncoprotein," will be presented at the 2013 Annual ... during the Developmental Therapeutics - Immunotherapy Oral Abstract ... 4:30 PM.  The presentation will describe the results ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: